Remote glucose check
This article was originally published in The Gray Sheet
Scottsdale, Ariz., health technology firm MedApps gains 510(k) clearance for its d-PAL remote monitoring system for diabetics July 3. The system connects to Johnson & Johnson/LifeScan's One Touch Ultra glucose monitor to allow wireless transfer of daily glucose readings to a central server. Patients can interact with the system via cell phone and remotely answer additional questions to give their doctors other pertinent information. MedApps, founded in July 2006, is developing similar products to monitor blood pressure in congestive heart failure patients, breathing efficiency for respiratory diseases, tremors in Parkinson's disease, and for use with implantable defibrillators and pacemakers...
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.